Adaptive Biotechnologies (ADPT) Short Interest Ratio & Short Volume → The Long-Awaited End of America Update (From Stansberry Research) (Ad) Free ADPT Stock Alerts $2.93 +0.14 (+5.02%) (As of 05/2/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Adaptive Biotechnologies Short Interest DataCurrent Short Volume10,010,000 sharesPrevious Short Volume9,100,000 sharesChange Vs. Previous Month+10.00%Dollar Volume Sold Short$29.13 millionShort Interest Ratio / Days to Cover6.0Last Record DateApril 15, 2024Outstanding Shares147,370,000 sharesFloat Size138,510,000 sharesShort Percent of Float7.23%Today's Trading Volume1,114,183 sharesAverage Trading Volume1,616,031 sharesToday's Volume Vs. Average69% Short Selling Adaptive Biotechnologies ? Sign up to receive the latest short interest report for Adaptive Biotechnologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADPT Short Interest Over TimeADPT Days to Cover Over TimeADPT Percentage of Float Shorted Over Time Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Adaptive Biotechnologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202410,010,000 shares $29.13 million +10.0%7.2%6 $2.91 3/31/20249,100,000 shares $29.21 million +7.6%6.6%6.1 $3.21 3/15/20248,460,000 shares $27.41 million -3.5%6.1%5.9 $3.24 2/29/20248,770,000 shares $36.04 million -4.6%N/A5.9 $4.11 2/15/20249,190,000 shares $36.39 million +4.3%N/A6.6 $3.96 1/31/20248,810,000 shares $32.33 million +0.6%N/A5.9 $3.67 Get the Latest News and Ratings for ADPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptive Biotechnologies and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,760,000 shares $38.54 million -7.4%N/A5.6 $4.40 12/31/20239,460,000 shares $46.35 million -1.3%N/A6.3 $4.90 12/15/20239,580,000 shares $46.65 million -8.7%N/A6 $4.87 11/30/202310,490,000 shares $45.95 million -6.6%N/A6.8 $4.38 11/15/202311,230,000 shares $48.06 million +4.6%N/A7.3 $4.28 10/31/202310,740,000 shares $47.69 million +8.5%N/A7.7 $4.44 10/15/20239,900,000 shares $42.42 million -6.9%N/A7.4 $4.29 9/30/202310,630,000 shares $57.93 million +7.6%N/A8.1 $5.45 9/15/20239,880,000 shares $59.87 million -5.1%N/A8.4 $6.06 8/31/202310,410,000 shares $70.48 million +3.5%N/A9.1 $6.77 8/15/202310,060,000 shares $63.28 million +5.3%N/A8.7 $6.29 7/31/20239,550,000 shares $80.60 million +6.4%N/A8.8 $8.44 7/15/20238,980,000 shares $64.39 million +12.1%N/A8.9 $7.17 6/30/20238,010,000 shares $53.75 million -0.9%5.8%7.9 $6.71 6/15/20238,080,000 shares $70.05 million +10.4%5.8%8.2 $8.67 5/31/20237,320,000 shares $50.95 million +10.4%5.3%8.2 $6.96 5/15/20236,630,000 shares $43.03 million +8.9%4.8%7.7 $6.49 4/30/20236,090,000 shares $43.48 million +12.2%4.4%6.7 $7.14 4/15/20235,430,000 shares $42.95 million -11.3%3.9%5.9 $7.91 3/31/20236,120,000 shares $54.04 million +14.8%4.4%6.4 $8.83 3/15/20235,330,000 shares $43.81 million +9.5%3.9%5.3 $8.22 2/28/20234,870,000 shares $41.64 million +9.4%3.5%4.9 $8.55 2/15/20234,450,000 shares $44.63 million -6.3%3.2%4.4 $10.03 1/31/20234,750,000 shares $44.03 million -12.4%3.4%4.7 $9.27 1/15/20235,420,000 shares $53.87 million -8.3%3.9%5.2 $9.94 12/30/20225,910,000 shares $45.15 million +25.0%4.2%5.8 $7.64 12/15/20224,730,000 shares $38.45 million -11.1%3.4%4.7 $8.13 11/30/20225,320,000 shares $46.71 million +3.3%3.8%5.2 $8.78 11/15/20225,150,000 shares $46.81 million -13.9%3.7%4.9 $9.09 10/31/20225,980,000 shares $46.52 million -2.3%4.3%5.4 $7.78 10/15/20226,120,000 shares $38.31 million -5.1%4.4%5.4 $6.26 9/30/20226,450,000 shares $45.92 million +3.4%4.6%5.7 $7.12 9/15/20226,240,000 shares $52.67 million -9.4%4.5%4.4 $8.44 8/31/20226,890,000 shares $61.46 million +6.0%4.9%4.4 $8.92Gold Mania (Ad)Former Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. ADPT Short Interest - Frequently Asked Questions What is Adaptive Biotechnologies' current short interest? Short interest is the volume of Adaptive Biotechnologies shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 10,010,000 shares of ADPT short. 7.23% of Adaptive Biotechnologies' shares are currently sold short. Learn More on Adaptive Biotechnologies' current short interest. What is a good short interest ratio for Adaptive Biotechnologies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADPT shares currently have a short interest ratio of 6.0. Learn More on Adaptive Biotechnologies's short interest ratio. Which institutional investors are shorting Adaptive Biotechnologies? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Adaptive Biotechnologies: Concourse Financial Group Securities Inc., Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Adaptive Biotechnologies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.23% of Adaptive Biotechnologies' floating shares are currently sold short. Is Adaptive Biotechnologies' short interest increasing or decreasing? Adaptive Biotechnologies saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 10,010,000 shares, an increase of 10.0% from the previous total of 9,100,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Adaptive Biotechnologies' float size? Adaptive Biotechnologies currently has issued a total of 147,370,000 shares. Some of Adaptive Biotechnologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Adaptive Biotechnologies currently has a public float of 138,510,000 shares. How does Adaptive Biotechnologies' short interest compare to its competitors? 7.23% of Adaptive Biotechnologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Adaptive Biotechnologies: iTeos Therapeutics, Inc. (7.43%), Replimune Group, Inc. (18.75%), TScan Therapeutics, Inc. (1.09%), Aura Biosciences, Inc. (6.50%), Jasper Therapeutics, Inc. (4.18%), Tenaya Therapeutics, Inc. (5.41%), Tourmaline Bio, Inc. (11.58%), Lexeo Therapeutics, Inc. (5.21%), Ocugen, Inc. (17.58%), Solid Biosciences Inc. (3.47%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Adaptive Biotechnologies stock? Short selling ADPT is an investing strategy that aims to generate trading profit from Adaptive Biotechnologies as its price is falling. ADPT shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Adaptive Biotechnologies? A short squeeze for Adaptive Biotechnologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADPT, which in turn drives the price of the stock up even further. How often is Adaptive Biotechnologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADPT, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: iTeos Therapeutics Short Interest Data Replimune Group Short Interest Data TScan Therapeutics Short Interest Data Aura Biosciences Short Interest Data Jasper Therapeutics Short Interest Data Tenaya Therapeutics Short Interest Data Tourmaline Bio Short Interest Data Lexeo Therapeutics Short Interest Data Ocugen Short Interest Data Solid Biosciences Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADPT) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits4 coins to be the “Next Bitcoin”True Market Insiders